The effect of 6-hydroxydopamine and some hypotensive drugs on lypressin induced hypertension in rats

Pol J Pharmacol Pharm. 1985 Jul-Aug;37(4):487-93.

Abstract

Intracerebroventricular injection of 6-hydroxydopamine (6-OH-DA) prevented the development of the lypressin (LVP)-induced hypertension. Administration of 6-OH-DA to hypertensive rats significantly decreased, but did not normalize, blood pressure. A fourteen-day treatment with clonidine, guanethidine, reserpine, dihydralazine, propranolol and furosemide produced a transient decrease in blood pressure in LVP-hypertensive rats. Eight weeks after the withdrawal of hypotensive drugs blood pressure again reached the value corresponding to that in untreated LVP-hypertensive rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology*
  • Brain / drug effects
  • Brain / metabolism
  • Cerebral Ventricles / drug effects
  • Cerebral Ventricles / physiology
  • Hydralazine / pharmacology
  • Hydroxydopamines / administration & dosage
  • Hydroxydopamines / pharmacology*
  • Hypertension / chemically induced
  • Hypertension / physiopathology*
  • Injections, Intraventricular
  • Lypressin
  • Male
  • Norepinephrine / metabolism
  • Oxidopamine
  • Propranolol / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Reserpine / pharmacology

Substances

  • Antihypertensive Agents
  • Hydroxydopamines
  • Hydralazine
  • Lypressin
  • Reserpine
  • Oxidopamine
  • Propranolol
  • Norepinephrine